Shunwei Capital’s sub-fund Shenzhen Shunying Private Equity Investment is raising 1 billion yuan ($154 million) for a new fund. In a separate development, Yeasen Biotechnology (Shanghai) has landed 300 million yuan ($46 million) in a Series B+ round.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in